Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment
Avtorji:ID Koceva, Andrijana (Avtor)
ID Janež, Andrej (Avtor)
ID Jensterle Sever, Mojca (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,41 MB)
MD5: FDF25620A7D2AF377C9377FF4F6F0E9C
 
URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/abs/pii/S1521690X25000715
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Obesity is rising among women of reproductive age and significantly contributes to subfertility. If conception occurs, maternal obesity is associated with increased risks for both maternal and neonatal complications, with potential long-term effects on the offspring's health. Current clinical guidelines emphasize the importance of preconception weight optimization in women with obesity to reduce maternal and fetal risks. Amid the rising use of incretin-based anti-obesity medications, particularly among young women, their potential role in preconception care is receiving growing clinical and research interest. With unplanned pregnancies remaining common, incidental exposure during early pregnancy is becoming more likely. In parallel, there is increasing interest in the potential of these agents to support preconception weight loss and enhance fertility outcomes in women with obesity. This narrative review examines the current human evidence on GLP-1 and dual GLP-1/GIP receptor agonists approved for obesity treatment, focusing on their potential role in preconception care and addressing key safety considerations and challenges related to their use during the preconception period, as well as inadvertent exposure in early pregnancy.
Ključne besede:GLP-1 receptor agonist, GLP-1/GIP receptor agonist, preconception care
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 1-10
Številčenje:Vol. 39, iss. 6
PID:20.500.12556/DiRROS-24894 Novo okno
UDK:616.4
ISSN pri članku:1521-690X
DOI:10.1016/j.beem.2025.102038 Novo okno
COBISS.SI-ID:250744067 Novo okno
Datum objave v DiRROS:23.12.2025
Število ogledov:6
Število prenosov:4
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Baillière's best practice & research. Clinical Endocrinology and metabolism
Skrajšan naslov:Baillière's Best Pract Res Clin Endocrinol Metab
Založnik:Baillière Tindall
ISSN:1521-690X
COBISS.SI-ID:2071060 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:agonist receptorja GLP-1, agonist receptorja GLP-1/GIP, predzanositvena oskrba


Nazaj